Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1Endocrine 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 57Neoplasms 11Lung Neoplasms 11Small Cell Lung Carcinoma 8Thyroid Neoplasms 7Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma 6Breast Neoplasms 6Adenocarcinoma 6Colorectal Neoplasms 5Colonic Neoplasms 5Thyroid Diseases 4Thyroid Cancer, Papillary 4Thoracic Neoplasms 4Sarcoma 4Respiratory Tract Neoplasms 4Respiratory Tract Diseases 4Pancreatic Neoplasms 4Neuroendocrine Tumors 4Neoplasms by Site 4Melanoma 4Lung Diseases 4Endometrial Neoplasms 4Endocrine System Diseases 4Endocrine Gland Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Bronchogenic 4Bronchial Neoplasms 4Uterine Cervical Neoplasms 3

Interventions

selpercatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Myofibromatosis × Thoracic × Clear all
NCT03899792 2026-01-06

LIBRETTO-121

Eli Lilly and Company

Phase 1/2 Active not recruiting
36 enrolled 13 charts 2 FDA
BreastCNSEndocrineGastrointestinalHead & NeckSarcomaThoracic

Thyroid Cancer, Papillary, Breast Neoplasms, Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Central Nervous System Neoplasms, Myofibromatosis, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡